In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 21, 2020
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Acute Coronary Syndrome (MeSH)
- Humans (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Prasugrel Hydrochloride (MeSH)
- Stroke (MeSH)
- Ticagrelor (MeSH)
published in
- ACP journal club Journal